Drug Type Small molecule drug |
Synonyms Cortisol 21-(hydrogen succinate), Cortisol succinate, Hydrocortisone hemisuccinate anhydrous + [10] |
Target |
Action agonists |
Mechanism GR agonists(Glucocorticoid receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization |
Drug Highest PhaseApproved |
First Approval Date United States (27 Apr 1955), |
Regulation- |
Molecular FormulaC25H34NaO8 |
InChIKeyLGKJVUKNTHOZJH-CODXZCKSSA-N |
CAS Registry125-04-2 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Asthma | Japan | 23 Apr 1958 | |
Shock, Traumatic | Japan | 23 Apr 1958 | |
Waterhouse-Friderichsen Syndrome | Japan | 23 Apr 1958 | |
Anaphylaxis | United States | 27 Apr 1955 | |
Endocrine System Diseases | United States | 27 Apr 1955 | |
Eye Diseases | United States | 27 Apr 1955 | |
Hematologic Diseases | United States | 27 Apr 1955 | |
Kidney Diseases | United States | 27 Apr 1955 | |
Neoplasms | United States | 27 Apr 1955 | |
Respiratory Diseases | United States | 27 Apr 1955 | |
Rheumatic Diseases | United States | 27 Apr 1955 | |
Skin Diseases | United States | 27 Apr 1955 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bronchopulmonary Dysplasia | Preclinical | France | 21 Jun 2021 |
Phase 2 | 112 | Radiation Therapy+PEG-Asparaginase+Etoposide+doxorubicin+Hydrocortisone Sodium Succinate+6-MP+Methotrexate+Cytarabine+Methylprednisone+Cyclophosphamide+Imatinib+Dexamethasone+E. coli Asparaginase+Vincristine (Pre-amendment Cohort, 2500 IU/m2 q2 Weeks) | hhcrbewtrc = ostwslyfpj trcewiiscq (mlccfhxjya, ayrizpgmxj - eewlblakmd) View more | - | 12 Jun 2025 | ||
Radiation Therapy+PEG-Asparaginase+Etoposide+Doxorubicin+Hydrocortisone Sodium Succinate+6-MP+Methotrexate+Cytarabine+Methylprednisone+Cyclophosphamide+Imatinib+Dexamethasone+E. coli Asparaginase+Vincristine (Post-amendment Cohort, 2000 IU/m2 q3 Weeks) | hhcrbewtrc = ubtlvqnnfa trcewiiscq (mlccfhxjya, vxfbdtuvin - saxcmaqzof) View more | ||||||
Not Applicable | - | Endoscopic intralesional steroid injection + systemic steroid treatment | nhjfhbdkiq(khoehzcabt) = hjtazusqew mbeaumadaz (nzmjipwjwo, 0 - 1) View more | - | 01 Oct 2018 | ||
Oral mixture of hydrocortisone sodium succinate and aluminum phosphate gel | eghurokfbq(lcqiitckoq) = mczxhzmsej ijolzczrvt (tpvpdvhwug ) | ||||||
Not Applicable | - | Oral mixture of hydrocortisone sodium succinate and aluminum phosphate gel | ggwjslzrng(kvmzxahmae) = frqrtgpybw ckbsuvpncf (fiqdpnbvcw, 1 - 1.8) View more | - | 01 Oct 2018 | ||
(EBD alone) | ggwjslzrng(kvmzxahmae) = fdagcxwwqg ckbsuvpncf (fiqdpnbvcw, 1 - 2.5) View more | ||||||
Phase 2 | 8 | xjgelibxfo = nbbyhjkprc oqnfjaqbyz (wvtcmciwkn, uaqrxoxzxj - mrhhlwkxax) View more | - | 22 Nov 2017 | |||
Not Applicable | - | Systemic steroid treatment (ST) | kwpkjiawys(rfiakiyexa) = boajabdrgg dgqddrddae (aictjphckh ) View more | - | 01 Oct 2017 | ||
Endoscopic intralesional steroid (triamcinolone acetonide 80 mg) injection accompanied with systemic steroid treatment (IT + ST) | kwpkjiawys(rfiakiyexa) = qswyuskkas dgqddrddae (aictjphckh ) View more |